| human | Q5 |
| P106 | occupation | author | Q482980 |
| Q34714538 | A new high-throughput screening method for the detection of chronic lymphatic leukemia and myelodysplastic syndrome |
| Q60187343 | A routine-qualified flow cytometric method for the identification of multiple sclerosis patients with a reduced therapeutic effectiveness of natalizumab |
| Q37770117 | A systematic review of cost-effectiveness analyses of pharmacogenetic-guided dosing in treatment with coumarin derivatives |
| Q40995378 | Adaptive Immune Responses in a Multiple Sclerosis Patient with Acute Varicella-Zoster Virus Reactivation during Treatment with Fingolimod |
| Q50057818 | Are laboratory tests always needed? Frequency and causes of laboratory overuse in a hospital setting |
| Q91246836 | Beyond LNB: Real life data on occurrence and extent of CSF CXCL13 in neuroinflammatory diseases |
| Q61446158 | Cerebrospinal fluid CXLC13 indicates disease course in neuroinfection: an observational study |
| Q89847251 | Chemokine CXCL13 in serum, CSF and blood-CSF barrier function: evidence of compartment restriction |
| Q39487830 | Clinical and Metabolic Characterization of Lean Caucasian Subjects With Non-alcoholic Fatty Liver. |
| Q51130476 | Clinical decision rules for the use of liquor diagnostics in hospitalized neurology patients reduced costs without affecting clinical outcomes. |
| Q48205002 | Coronary angiography as a rare cause for incomplete anterior spinal artery syndrome |
| Q38042441 | Cost-effectiveness of pharmacogenetics in anticoagulation: international differences in healthcare systems and costs |
| Q90697789 | Development and Characterization of the Neuroregenerative Xanthohumol C/Hydroxypropyl-β-cyclodextrin Complex Suitable for Parenteral Administration |
| Q50501442 | Does docosahexaenoic acid (DHA) status in pregnancy have any impact on postnatal growth? Six-year follow-up of a prospective randomized double-blind monocenter study on low-dose DHA supplements. |
| Q52925762 | Does maternal docosahexaenoic acid supplementation during pregnancy and lactation lower BMI in late infancy? |
| Q52601474 | Dynamic reference intervals for coagulation parameters from infancy to adolescence. |
| Q99707289 | Effect of two organizational interventions on the frequency of haemoglobin A1c and erythrocyte sedimentation rate testing |
| Q48710629 | Effectiveness of a Laboratory Gate-Keeping Strategy to Overcome Inappropriate Test Utilization for the Diagnosis of Heparin-Induced Thrombocytopenia. |
| Q45789037 | Elevated plasma levels of interleukin-16 in patients with acute myocardial infarction |
| Q96578036 | Errors within the total laboratory testing process, from test selection to medical decision-making - A review of causes, consequences, surveillance and solutions |
| Q38083396 | Evaluation of growth and early infant feeding: a challenge for scientists, industry and regulatory bodies |
| Q38130883 | Feeding patterns during the first 2 years and health outcome |
| Q43847434 | First detection of the Anaplasma phagocytophilum groEL-A genotype in man. |
| Q31155663 | From natalizumab to fingolimod in eight weeks - Immunological, clinical, and radiological data in quest of the optimal switch |
| Q43258272 | Genotype-guided dosing of coumarin derivatives: the European pharmacogenetics of anticoagulant therapy (EU-PACT) trial design |
| Q45398119 | Growth and metabolism of infants born to women infected with human immunodeficiency virus and fed acidified whey-adapted starter formulas |
| Q38734899 | Hemeoxygenase-1 as a Novel Driver in Ritonavir-Induced Insulin Resistance in HIV-1-Infected Patients |
| Q38801799 | Hemolysis rates in blood samples: differences between blood collected by clinicians and nurses and the effect of phlebotomy training |
| Q92389966 | Heparin and citrate additive carryover during blood collection |
| Q28259237 | Homocysteine, folate and vitamin B12 in neuropsychiatric diseases: review and treatment recommendations |
| Q60486720 | Impact of CYP2C8 and 2C9 Polymorphisms on Coronary Artery Disease and Myocardial Infarction in the LURIC Cohort |
| Q38017920 | Impact of CYP2D6 polymorphism on tamoxifen therapy: where are we? |
| Q42904774 | Impact of CYP2D6*4 genotype on progression free survival in tamoxifen breast cancer treatment. |
| Q35558084 | Impact of UGT2B7 His268Tyr polymorphism on the outcome of adjuvant epirubicin treatment in breast cancer. |
| Q89831585 | Inappropriate use of laboratory tests: How availability triggers demand - Examples across Europe |
| Q47149826 | Influence of centrifugation conditions on the results of 77 routine clinical chemistry analytes using standard vacuum blood collection tubes and the new BD-Barricor tubes |
| Q99604118 | Influence of dabigatran on pro-inflammatory cytokines, growth factors and chemokines - Slowing the vicious circle of coagulation and inflammation |
| Q81812861 | Intraplatform reproducibility and technical precision of gene expression profiling in 4 laboratories investigating 160 leukemia samples: the DACH study |
| Q100407289 | Long-term peripheral immune cell profiling reveals further targets of oral cladribine in MS |
| Q37707133 | Low Protein Formula: Consequences of Quantitative Effects of Pre-analytical Factors on Amino Acid Concentrations in Plasma of Healthy Infants |
| Q28731914 | Lymphocyte subsets show different response patterns to in vivo bound natalizumab--a flow cytometric study on patients with multiple sclerosis |
| Q90870894 | Managing inappropriate utilization of laboratory resources |
| Q37570977 | Metabolomic profiling identifies potential pathways involved in the interaction of iron homeostasis with glucose metabolism. |
| Q48165741 | Multibiomarker analysis in patients with acute myocardial infarction |
| Q60187476 | Natalizumab therapy decreases surface expression of both VLA-heterodimer subunits on peripheral blood mononuclear cells |
| Q85088579 | Novel mutation at codon 110 of the human APOE gene: impact on genotyping with fluorescent hybridization probes |
| Q42232748 | Performance characteristics of the COBAS Ampliprep/COBAS TaqMan v2.0 and the Abbott RealTime hepatitis C assays - implications for response-guided therapy in genotype 1 infections |
| Q90763733 | Reducing the probability of falsely elevated HbA1c results in diabetic patients by applying automated and educative HbA1c re-testing intervals |
| Q40676832 | Reference values of amino acids and of common clinical chemistry in plasma of healthy infants aged 1 and 4 months |
| Q86835005 | Relevance of EDTA carryover during blood collection |
| Q60187346 | Routine-taugliche durchflusszytometrische Methode zur Identifikation von Multiple Sklerose PatientInnen mit einer nicht ausreichenden Therapieeffizienz unter einer Natalizumab-Therapie |
| Q60187332 | Serial flow cytometric analyses of blood and cerebrospinal fluid in natalizumab-associated progressive multifocal leukencephalopathy with an excellent outcome |
| Q46419983 | Specific circulating phospholipids, acylcarnitines, amino acids and biogenic amines are aerobic exercise markers |
| Q37466009 | Supplementation with 200 mg/day docosahexaenoic acid from mid-pregnancy through lactation improves the docosahexaenoic acid status of mothers with a habitually low fish intake and of their infants |
| Q38310756 | TaqManR proximity ligation technology for the detection of heterodimeric adhesion receptors on lymphocytes |
| Q33740602 | The Human NADPH Oxidase, Nox4, Regulates Cytoskeletal Organization in Two Cancer Cell Lines, HepG2 and SH-SY5Y. |
| Q92041025 | The clinically effective use of cardiac markers by restructuring laboratory profiles at Cardiology wards |
| Q85277980 | The economic burden of hemolysis |
| Q64092005 | The endogenous cardiotonic steroid Marinobufagenin and decline in estimated glomerular filtration rate at follow-up in patients with arterial hypertension |
| Q39010043 | The relationship between vacuum and hemolysis during catheter blood collection: a retrospective analysis of six large cohorts |
| Q60187410 | Therapeutisches Drug-Monitoring der Natalizumab-Sättigung von Immunzellen mittels Durchflusszytometrie bei Multipler Sklerose/Flow cytometry and drug monitoring of natalizumab saturation of immune cells in multiple sclerosis |
| Q47342914 | To report or not to report: a proposal on how to deal with altered test results in hemolytic samples |
| Q43549712 | Urinary D-lactate excretion in infants receiving Lactobacillus johnsonii with formula |
| Q40988508 | What´s floating on my plasma? |
| Q44156982 | Whey predominant, whey modified infant formula with protein/energy ratio of 1.8 g/100 kcal: adequate and safe for term infants from birth to four months |
Search more.